PURPOSE: The purpose of this study was to identify the effects of violence experience, emotional labor and job stress on clinical nurses' depression and to provide suggestions for improving the quality of patient care. METHODS: This research involved 257 clinical nurses who were working at an acute care hospital with at least 200 beds in S city and K province. Data were collected from May 23 to June 7 in 2014 and were analyzed using IBM SPSS version 21.0. RESULTS: The results show that 98.1% of subjects had violence experience in the past year and the violence experience included 44.4% physical threat, 37.5% verbal violence and 18.1% physical violence. The average scores were emotional labor 3.57, job stress 3.54 and depression 21.16. There were positive correlations among violence experience, emotional labor, job stress and depression (p<.01). There were also significant co-relationships between depression and violence experience (r=.21, p=.001), between depression and emotional labor (r=.48, p<.001) and between depression and job stress (r=.31, p<.001). CONCLUSION: The results suggest that it is necessary to set up guidelines for clinical nurses to manage violence, emotional labor and job stress in order to create better working environment and to improve quality of patient care.
Depression* ; Patient Care ; Violence*

Familial adenomatous polyposis (FAP) is an autosomal dominant genetic disorder caused by mutations in the adenomatous polyposis coli gene. FAP is characterized by the development of hundreds to thousands of adenomatous polyps in the colon. While initially the primary concern was colorectal cancer, recent advancements in surveillance and prophylactic colectomy have shifted the focus toward the management of upper gastrointestinal (GI) neoplasms, particularly duodenal and gastric lesions. This review focuses on the epidemiology, clinical features, treatment options, and surveillance strategies for treating upper GI neoplasms in patients suffering from FAP. A review of the risk assessment through the Spigelman classification system and current guidelines for both nonampullary and ampullary lesions was conducted for duodenal neoplasms. Regarding gastric neoplasms, the characteristics and management strategies for fundic gland polyps, gastric adenomas, and cancers were discussed. Overall, early screening and timely removal of suspicious lesions are crucial for the management of upper GI neoplasms in patients with FAP for effective cancer prevention.

Familial adenomatous polyposis (FAP) is an autosomal dominant genetic disorder caused by mutations in the adenomatous polyposis coli gene. FAP is characterized by the development of hundreds to thousands of adenomatous polyps in the colon. While initially the primary concern was colorectal cancer, recent advancements in surveillance and prophylactic colectomy have shifted the focus toward the management of upper gastrointestinal (GI) neoplasms, particularly duodenal and gastric lesions. This review focuses on the epidemiology, clinical features, treatment options, and surveillance strategies for treating upper GI neoplasms in patients suffering from FAP. A review of the risk assessment through the Spigelman classification system and current guidelines for both nonampullary and ampullary lesions was conducted for duodenal neoplasms. Regarding gastric neoplasms, the characteristics and management strategies for fundic gland polyps, gastric adenomas, and cancers were discussed. Overall, early screening and timely removal of suspicious lesions are crucial for the management of upper GI neoplasms in patients with FAP for effective cancer prevention.

Familial adenomatous polyposis (FAP) is an autosomal dominant genetic disorder caused by mutations in the adenomatous polyposis coli gene. FAP is characterized by the development of hundreds to thousands of adenomatous polyps in the colon. While initially the primary concern was colorectal cancer, recent advancements in surveillance and prophylactic colectomy have shifted the focus toward the management of upper gastrointestinal (GI) neoplasms, particularly duodenal and gastric lesions. This review focuses on the epidemiology, clinical features, treatment options, and surveillance strategies for treating upper GI neoplasms in patients suffering from FAP. A review of the risk assessment through the Spigelman classification system and current guidelines for both nonampullary and ampullary lesions was conducted for duodenal neoplasms. Regarding gastric neoplasms, the characteristics and management strategies for fundic gland polyps, gastric adenomas, and cancers were discussed. Overall, early screening and timely removal of suspicious lesions are crucial for the management of upper GI neoplasms in patients with FAP for effective cancer prevention.